Afuco™ Anti-Human CXCL12 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-CXCL12 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The human monoclonal antibodies that specifically bind to SDF-1 with high affinity can be used for detecting SDF-1, as well as treating various B cell malignancies, including breast cancer, multiple myeloma and non-Hodgkin's lymphoma, and autoimmune disorders.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-189CL |
| Pricing | Inquiry |
| Host | Human |
| Target | CXCL12 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Short term: store at 4°C (over 6 months), long term: -20°C or -80°C. |